{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:53:46Z","timestamp":1780318426686,"version":"3.54.1"},"reference-count":25,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2025,2,5]]},"DOI":"10.18632\/oncotarget.28686","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T14:13:51Z","timestamp":1738764831000},"page":"44-50","source":"Crossref","is-referenced-by-count":3,"title":["A case report of donor cell-derived hematologic neoplasms 9 years after allogeneic hematopoietic cell transplantation"],"prefix":"10.18632","volume":"16","author":[{"given":"Aleksandra","family":"Mroczkowska-B\u0119karciak","sequence":"first","affiliation":[{"name":"Department and Clinic of Hematology, Cellular Therapies and Internal Medicine, Wroclaw Medical University, Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Wr\u00f3bel","sequence":"additional","affiliation":[{"name":"Department and Clinic of Hematology, Cellular Therapies and Internal Medicine, Wroclaw Medical University, Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/s0140-6736(71)90998-6","article-title":"Leukaemic transformation of engrafted human marrow cells","volume":"1","author":"Neiman","year":"1971","journal-title":"Lancet"},{"key":"2","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/0145-2126(82)90067-4","article-title":"The incidence of recurrence of leukemia in donor cells after allogeneic bone marrow transplantation","volume":"6","author":"Thomas","year":"1982","journal-title":"Leuk Res"},{"key":"3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/14653240701466339","article-title":"Four cases of donor cell-derived AML following unrelated cord blood transplantation for adult patients: experiences of the Tokyo Cord Blood Bank","volume":"9","author":"Asano","year":"2007","journal-title":"Cytotherapy"},{"key":"4","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/leu.2016.23","article-title":"Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation","volume":"3","author":"Hashii","year":"2016","journal-title":"Leukemia"},{"key":"5","first-page":"969","article-title":"Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT)","volume":"9","author":"Bornh\u00e4user","year":"2005","journal-title":"Haematologica"},{"key":"6","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41375-018-0218-6","article-title":"European experience and risk factor analysis of donor cell-derived leukaemias\/MDS following haematopoietic cell transplantation","volume":"3","author":"Tischer","year":"2019","journal-title":"Leukemia"},{"key":"7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/bjh.12847","article-title":"Donor-derived myelodysplastic syndrome and acute leukaemia after allogeneic haematopoietic stem cell transplantation: incidence, natural history and treatment response","volume":"16","author":"Wagner","year":"2014","journal-title":"Br J Haematol"},{"key":"8","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.hemonc.2017.05.009","article-title":"Long-term complications after hematopoietic cell transplantation","volume":"1","author":"Majhail","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"9","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.bbmt.2018.01.033","article-title":"Donor Cell-Derived Hematologic Neoplasms after Hematopoietic Stem Cell Transplantation: A Systematic Review","volume":"2","author":"Bu\u00f1o","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jtct.2023.10.018","article-title":"Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation","volume":"3","author":"Sucheston-Campbell","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"11","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1182\/blood.2022017578","article-title":"Genetic basis and molecular profiling in myeloproliferative neoplasms","volume":"14","author":"Skoda","year":"2023","journal-title":"Blood"},{"key":"12","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1007\/s12185-017-2241-1","article-title":"Somatic SETBP1 mutations in myeloid neoplasms","volume":"10","author":"Makishima","year":"2017","journal-title":"Int J Hematol"},{"key":"13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/MOH.0b013e32834b6158","article-title":"Prevention and treatment of acute myeloid leukemia relapse after allogeneic stem cell transplantation","volume":"1","author":"de Lima","year":"2011","journal-title":"Curr Opin Hematol"},{"key":"14","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.3324\/haematol.2019.245688","article-title":"History of hematopoietic cell transplantation: challenges and progress","volume":"10","author":"Storb","year":"2020","journal-title":"Haematologica"},{"key":"15","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41409-018-0171-z","article-title":"Epidemiology and biology of relapse after stem cell transplantation","volume":"5","author":"Kr\u00f6ger","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"16","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1038\/s41409-021-01214-z","article-title":"Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome","volume":"5","author":"Lai","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/life12040559","article-title":"Lessons Learned from Donor Cell-Derived Myeloid Neoplasms: Report of Three Cases and Review of the Literature","volume":"1","author":"Kelemen","year":"2022","journal-title":"Life (Basel)"},{"key":"18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1537-2995.2008.02008.x","article-title":"Synchronous development of acute myeloid leukemia in recipient and donor after allogeneic bone marrow transplantation: report of a case with comments on donor evaluation","volume":"4","author":"Butera","year":"2009","journal-title":"Transfusion"},{"key":"19","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.1182\/blood.V126.23.5403.5403","article-title":"ASXL1-Mutated Donor HSCs Evolved into FLT3-ITD Positive AML in the Unrelated Donor and FLT3-ITD Negative AML in the Recipient after Transplant","volume":"12","author":"Sun","year":"2015","journal-title":"Blood"},{"key":"20","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1182\/blood-2010-12-326322","article-title":"First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Lin","year":"2011","journal-title":"Blood"},{"key":"21","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/leu.2017.44","article-title":"Donor cell leukemia arising from preleukemic clones with a novel germline DDX41 mutation after allogenic hematopoietic stem cell transplantation","volume":"3","author":"Yamamura","year":"2017","journal-title":"Leukemia"},{"key":"22","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1182\/blood-2018-07-861070","article-title":"Donor-derived MDS\/AML in families with germlinemutation","volume":"13","author":"Holland","year":"2018","journal-title":"Blood"},{"key":"23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"12","author":"Ebert","year":"2015","journal-title":"Blood"},{"key":"24","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1182\/blood-2006-07-021980","article-title":"Donor cell leukemia: insight into cancer stem cells and the stem cell niche","volume":"10","author":"Kaufman","year":"2007","journal-title":"Blood"},{"key":"25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2174\/157339406777934717","article-title":"Cancer therapy-induced residual bone marrow injury-Mechanisms of induction and implication for therapy","volume":"2","author":"Zhou","year":"2006","journal-title":"Curr Cancer Ther Rev"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T13:08:11Z","timestamp":1739192891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.28686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2,5]]}},"alternative-id":["28686","39907609"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.28686","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]}}}